{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:35:23Z","timestamp":1790879723945,"version":"4.1.0"},"reference-count":21,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Testing cosmetics and their ingredients is essential to avoid missing relevant allergens and to monitor fluctuating incidence of hypersensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to review the usefulness of patch testing with a customized antimicrobials, vehicles, and cosmetics (AVC) series over 15 years at a single Canadian site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between January 1, 2005, and December 31, 2019, patients suspected of having cosmetics allergy were patch tested with a 40-allergen AVC series in addition to the North American Contact Dermatitis Group standard screening series. We reviewed the patch test results of 2868 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We consecutively patch tested with the baseline series 6103 patients, of which 2868 (47%) were also tested with the AVC series. Of 53 different allergens that were tested at some point, 26 remained in the series throughout the 15-year span. The most common positive allergens were thimerosal (4.52%), polyvidone-iodine (2.25%), propolis (2.06%), sodium metabisulfite (1.94%), dodecyl gallate (1.53%), carmine (1.10%), lauryl glucoside (1.01%), sandalwood oil (0.7%), and\n                      <jats:italic toggle=\"yes\">tert<\/jats:italic>\n                      -butylhydroquinone (0.7%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although the expansion of the North American Contact Dermatitis Group standard screening series has decreased the yield from the AVC series from 21.1% to 13.9%, it still remains a useful adjunct for patients suspected of having cosmetics or disinfectants allergy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/der.0000000000000674","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T18:01:00Z","timestamp":1603044060000},"page":"367-372","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Expanding Patch Testing Beyond the Baseline Series"],"prefix":"10.1177","volume":"31","author":[{"given":"Catherine Besner","family":"Morin","sequence":"first","affiliation":[{"name":"From the Division of Dermatology, McGill University Health Centre, Montreal General Hospital, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Sasseville","sequence":"additional","affiliation":[{"name":"From the Division of Dermatology, McGill University Health Centre, Montreal General Hospital, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000296"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajcd.2002.31366"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2008.01559.x"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00499.x"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12838"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00479.x"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000263"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02126.x"},{"issue":"10","key":"e_1_3_1_10_2","first-page":"688","article-title":"Sensitization to gallates: review of 46 cases [in Spanish]","volume":"98","author":"Garcia-Melgares ML","year":"2007","unstructured":"Garcia-Melgares ML, , de la Cuadra J, , Martin B, et al. Sensitization to gallates: review of 46 cases [in Spanish]. Actas Dermosifiliogr, 2007; 98(10):688\u2013693.","journal-title":"Actas Dermosifiliogr"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1992.tb00238.x"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2012.00941.x"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000097"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000386"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12763"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000465"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12799"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2007.01073.x"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03619.x"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.470308_16.x"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.0650d.x"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0b013e318277ca50"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000674","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0000000000000674","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:05:27Z","timestamp":1777399527000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000674"}},"subtitle":["Usefulness of Customized Antimicrobials, Vehicles, and Cosmetics Series"],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12,1]]}},"alternative-id":["10.1097\/DER.0000000000000674"],"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000674","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}